-
201por Tanaka, Fumika, Katayama, Kan, Joh, Kensuke, Tsujimoto, Kayo, Yamawaki, Masahiro, Saiki, Ryosuke, Kurita, Tairo, Murata, Tomohiro, Dohi, KaoruEnlace del recurso
Publicado 2021
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
202
-
203COVID-19-Vaccine-Pfizer-BioNTech: Eosinophilic granulomatosis with polyangiitis relapse: case reportPublicado 2022Enlace del recurso
Enlace del recurso
Online Artículo Texto -
204
-
205
-
206
-
207
-
208“…We are reviewing the COVID-19 vaccines authorized for use in the United States by discussing the mechanisms of action, administration, side effects, and efficacy of vaccines developed by Pfizer, Moderna, and Johnson & Johnson. Pfizer and Moderna developed mRNA vaccines, encoding the spike protein of SARS-CoV-2, whereas Johnson & Johnson developed an adenovirus vector-based vaccine. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
209
-
210
-
211
-
212
-
213por Alamri, Awadh, Alghamdi, Yara, Alamri, Safa J, Althaqafi, Malak K, AlQurashi, Wasan, Bader, Bader A, Mohanna, Abdulrahman T, Almahdi, Bashaer“…COVID-19 is inflicted by SARS-CoV-2 and resulted in a global health crisis that necessitated the urgency of vaccine development to prevent its spreading among the public. Pfizer-BioNTech COVID-19 is one of the emergency use authorized (EUA) vaccines. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
214
-
215por Li, Chunfeng, Lee, Audrey, Grigoryan, Lilit, Arunachalam, Prabhu S., Scott, Madeleine K. D., Trisal, Meera, Wimmers, Florian, Sanyal, Mrinmoy, Weidenbacher, Payton A., Feng, Yupeng, Adamska, Julia Z., Valore, Erika, Wang, Yanli, Verma, Rohit, Reis, Noah, Dunham, Diane, O’Hara, Ruth, Park, Helen, Luo, Wei, Gitlin, Alexander D., Kim, Peter, Khatri, Purvesh, Nadeau, Kari C., Pulendran, BaliEnlace del recurso
Publicado 2022
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
216
-
217
-
218por Lukaszuk, Krzysztof, Podolak, Amira, Malinowska, Paulina, Lukaszuk, Jakub, Jakiel, Grzegorz“…The distribution of antibody levels was not significantly different between those who received the Pfizer vaccine alone and those receiving the AstraZeneca vaccine plus Pfizer or Pfizer and AstraZeneca. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
219por Shashar, Moshe, Nacasch, Naomi, Grupper, Ayelet, Benchetrit, Sydney, Halperin, Tamar, Erez, Daniel, Rozenberg, Ilan, Shitrit, Pnina, Sela, Yaron, Wand, Ori, Cohen-Hagai, Keren“…METHODS: The study included 102 MHD patients vaccinated with 2 doses of the BNT162b2 (Pfizer-BioNTech) vaccine. A third dose (booster) was recommended to all MHD patients in our center and was given to those who opted to receive it, resulting in a booster group and a control group that did not receive the booster. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
220